Literature DB >> 35932445

Complications in Device Therapy: Spectrum, Prevalence, and Management.

J Llewellyn1, D Garner2,3, A Rao2.   

Abstract

PURPOSE OF REVIEW: Cardiac implantable electronic device implant numbers are continually increasing due to the expanding indications and ageing population. This review explores the complications associated with device therapy and discusses ways to minimise and manage such complications. RECENT
FINDINGS: Complications related to device therapy contribute to mortality and morbidity. Recent publications have detailed clear guidelines for appropriate cardiac device selection, as well as consensus documents discussing care quality and optimal implantation techniques. There have also been advances in device technologies that may offer alternative options to patients at high risk of/or already having encountered a complication. Adherence to guidelines, appropriate training, and selection of device, in addition to good surgical technique are key in reducing the burden of complications and improving acceptability of device therapy.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Complications; Device therapy; Management

Mesh:

Year:  2022        PMID: 35932445     DOI: 10.1007/s11897-022-00563-0

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  60 in total

1.  Complications arising after implantation of DDD pacemakers: the MOST experience.

Authors:  Kenneth A Ellenbogen; Anne S Hellkamp; Bruce L Wilkoff; Jorge L Camunãs; John C Love; Tom A Hadjis; Kerry L Lee; Gervasio A Lamas
Journal:  Am J Cardiol       Date:  2003-09-15       Impact factor: 2.778

2.  Transvenous defibrillation leads: high incidence of failure during long-term follow-up.

Authors:  Uwe Dorwarth; Bernhard Frey; Martin Dugas; Tomas Matis; Michael Fiek; Michael Schmoeckel; Thomas Remp; Ilka Durchlaub; Andrea Gerth; Gerhard Steinbeck; Ellen Hoffmann
Journal:  J Cardiovasc Electrophysiol       Date:  2003-01

3.  Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.

Authors:  Philip W Chui; Yongfei Wang; Isuru Ranasinghe; Teferi Y Mitiku; Arnold H Seto; Lindsey Rosman; Rachel Lampert; Karl E Minges; Alan D Enriquez; Jeptha P Curtis
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-06-12

4.  Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.

Authors:  Arun Raghav Mahankali Sridhar; Vivek Yarlagadda; Madhu Reddy Yeruva; Arun Kanmanthareddy; Ajay Vallakati; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  Europace       Date:  2015-04-07       Impact factor: 5.214

5.  Physician procedure volume and complications of cardioverter-defibrillator implantation.

Authors:  James V Freeman; Yongfei Wang; Jeptha P Curtis; Paul A Heidenreich; Mark A Hlatky
Journal:  Circulation       Date:  2011-11-17       Impact factor: 29.690

6.  2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

Authors:  Michael Glikson; Jens Cosedis Nielsen; Mads Brix Kronborg; Yoav Michowitz; Angelo Auricchio; Israel Moshe Barbash; José A Barrabés; Giuseppe Boriani; Frieder Braunschweig; Michele Brignole; Haran Burri; Andrew J S Coats; Jean-Claude Deharo; Victoria Delgado; Gerhard-Paul Diller; Carsten W Israel; Andre Keren; Reinoud E Knops; Dipak Kotecha; Christophe Leclercq; Béla Merkely; Christoph Starck; Ingela Thylén; José Maria Tolosana
Journal:  Eur Heart J       Date:  2021-09-14       Impact factor: 29.983

7.  Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.

Authors:  Andreas Schuchert; Carmine Muto; Themistoklis Maounis; Robert Frank; Eric Boulogne; Alexander Polauck; Luigi Padeletti
Journal:  Europace       Date:  2012-08-26       Impact factor: 5.214

8.  European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology.

Authors:  Suleman Aktaa; Amr Abdin; Elena Arbelo; Haran Burri; Kevin Vernooy; Carina Blomström-Lundqvist; Giuseppe Boriani; Pascal Defaye; Jean-Claude Deharo; Inga Drossart; Dan Foldager; Michael R Gold; Jens Brock Johansen; Francisco Leyva; Cecilia Linde; Yoav Michowitz; Mads Brix Kronborg; David Slotwiner; Torkel Steen; José Maria Tolosana; Stylianos Tzeis; Niraj Varma; Michael Glikson; Jens Cosedis Nielsen; Chris P Gale
Journal:  Europace       Date:  2022-01-04       Impact factor: 5.214

9.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.

Authors:  Rikke Esberg Kirkfeldt; Jens Brock Johansen; Ellen Aagaard Nohr; Ole Dan Jørgensen; Jens Cosedis Nielsen
Journal:  Eur Heart J       Date:  2013-12-17       Impact factor: 29.983

10.  A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association.

Authors:  M J Pekka Raatikainen; David O Arnar; Bela Merkely; Jens Cosedis Nielsen; Gerhard Hindricks; Hein Heidbuchel; John Camm
Journal:  Europace       Date:  2017-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.